Skip to main content
Clinical Trials/NCT02288104
NCT02288104
Completed
Not Applicable

Needle-based Confocal Laser Endomicroscopy in CT-guided Procedures in Interventional Radiology With Applications in Liver and Kidneys: a Feasibility Study

Mauna Kea Technologies1 site in 1 country16 target enrollmentJanuary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Liver Percutaneous Biopsy or Ablation
Sponsor
Mauna Kea Technologies
Enrollment
16
Locations
1
Primary Endpoint
Diagnostic accuracy (sensitivity specificity) of endomicroscopy as compared to histopathology
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This study is a prospective study in order to demonstrate the technical feasibility and safety of doing endomicroscopic imaging during interventional radiology procedure in two main indications: Kidneys and liver.

This innovative study will involve the use of probe-based confocal laser endomicroscopy. The proposed study is a feasibility study.

Detailed Description

Interventional radiology is a medical sub-specialty of radiology which utilizes minimally-invasive image-guided procedures to diagnose and treat diseases in nearly every organ. The concept behind interventional radiology is to diagnose and treat patients using less invasive techniques currently available in order to minimize risk to the patient and improve health outcomes. For many years, surgery was the only treatment available for many conditions. Today, interventional radiology treatments are frst-line care for a wide variety of conditions. Patients should be offered the least invasive option frst. It is important to get a second opinion and know all of your treatment options before consenting to any procedure or surgery. Interventional radiologists are specialists in minimally invasive treatments, have a unique breadth of training and provide consults to every type of specialist. Surgical removal of liver tumors offers the best chance for a cure. Unfortunately, liver tumors are often inoperable because the tumor may be too large, or has grown into major blood vessels or other vital structures. Sometimes, many small tumors are spread throughout the liver, making surgery too risky or impractical. Surgical removal is not possible for more than two-thirds of primary liver cancer patients and 90 percent of patients with secondary liver cancer. The objectives of this study are to demonstrate the technical feasibility and safety of doing endomicroscopic imaging during interventional radiology procedure in two main indications: liver and kidneys. The Primary objective is: To study and demonstrate the technical feasibility and safety of doing endomicroscopic imaging during interventional radiology procedure in two main indications: liver and kidney. The Secondary objectives are: 1. Assess the safety of the use of Endomicroscopic imaging during interventional radiology procedure in two main indications: liver and kidney. 2. Assess the quality of biopsies performed with the help of Cellvizio. 3. Build a database of images as an atlas and define image interpretation criteria in collaboration with pathologists. Evaluate whether and how Cellvizio can improve guidance for biopsies or ablations: for instance, in the critical structures such as nerves or vessels in the vicinity of the cryoablation area, is it possible to visualize ice crystals and therefore decide to stop the cryoablation at the right time/location? For both applications, technical feedback from the physicians is expected on how they think the combined use of the devices could change the care path. E.g. a certain step in the workflow might become obsolete or the workflow could lead to fewer patient visits. For the safety of this protocol, the use of endomicroscopy will not change in any way the patient management and standard procedure, including the diagnosis nor treatment decisions. All the adverse events / serious adverse events will be noted during the procedure and one week after the procedure.

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
March 17, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled to have an interventional radiology procedure for needle-biopsy or radiofrequency ablation purposes in liver or Kidney.
  • Only subjects who have provided written informed consent for the study can be included in the study.

Exclusion Criteria

  • Patients have a known allergy to fluorescein
  • Patient is Pregnant or breast-feeding
  • Patient under judiciary control
  • Patient under the tutelage of a guardian
  • Patient unable to sign the information consent form (in case of an emergency situation or difficulty in understanding the information)

Outcomes

Primary Outcomes

Diagnostic accuracy (sensitivity specificity) of endomicroscopy as compared to histopathology

Time Frame: up to 2 weeks

Assessment of the accuracy of Cellvizio confocal mini probe imaging guided by fluoroscopy at the tumor boundary compared with traditional histopathology from physical biopsies

Secondary Outcomes

  • Number of patients for whom endomicroscopy could have affected the clinical workflow(Up to 5 months)
  • Measure adverse events frequency in the use of mini probes on the tumor(Up to 1 week)
  • Percentage of biopsies guided by nCLE (needle-based Confocal Laser Endomicroscopy) which provide a definitive diagnosis as a measure of efficiency of endomicroscopy-targeted biopsies compared to traditional needle biopsies(Up to 5 months)
  • Classification of endomicroscopy images from benign and malignant conditions(Up to 6 months)

Study Sites (1)

Loading locations...

Similar Trials